Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...
MedPage Today on MSN
Cancer vaccines dogged by misinformation; 867-5309 for cancer; bee venom as therapy?
News, features, and commentary about cancer-related issues ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results